Chemistry: molecular biology and microbiology – Differentiated tissue or organ other than blood – per se – or... – Including perfusion; composition therefor
Patent
1992-04-08
1993-12-28
Robinson, Douglas W.
Chemistry: molecular biology and microbiology
Differentiated tissue or organ other than blood, per se, or...
Including perfusion; composition therefor
4352401, 4352402, 4352403, 43524031, 514564, C12N 500, A01N 102
Patent
active
052738752
ABSTRACT:
Physiologically active N.sup.6 -(hydrazinoiminomethyl)lysine or pharmaceutically acceptable acid addition salt thereof is administered in a nitric oxide synthesis inhibiting amount to a subject in need of such inhibition (e.g., a subject with low blood pressure, e.g., due to sepsis or to therapeutic administration of cytokines, or needing immunosuppressive effect) or is added to a medium containing isolated organs, intact cells, cell homogenates or tissue homogenates in an amount sufficient to inhibit nitric oxide formation to elucide or control the biosynthesis, metabolism or physiological role of nitric oxide. Comp
REFERENCES:
patent: 4282217 (1981-08-01), Baglioni et al.
patent: 4698442 (1987-10-01), Nestor et al.
patent: 5028627 (1991-07-01), Kilbourn et al.
patent: 5059712 (1991-10-01), Griffith
Vallance P., et al, Lancet, 28, 997-999 (1989).
Moncada, S., et al, Eur. J. Clin. Invest. 21, 361-374 (1991).
Moncada, S., et al, J. Cardiovascular Pharm. 17 (suppl. 3), S1-S9 (1991).
Moncada, S., et al, Pharmacological Reviews, 43(2), 109-142 (1991).
Parrat, J. R., et al, Applied Cardiopulmonary Pathophysiology, 4, 143-149 (1991).
Wang, Q., et al, Life Sciences 49: PL-55-PL-60 (1991).
Aisaka, K., et al, Biochemical and Biophysic Research Communications, vol. 160, No. 2, pp. 881-886, Apr. 28, 1989.
Iyengar, R., et al, Proc. Natl. Acad. Sci, USA, vol. 84, pp. 6369-6373 Sep. 1987.
Palmer, R. M. J., et al, Nature (London), 333, pp. 664-666, 1988.
Rees, D. D., et al, Proc. Natl. Acad. Sci. USA, vol. 86, pp. 3375-3378, May 1989.
Palmer, R. M. J., et al, Biochem and Biophysical Research Communications, 153, No. 3, 1251-1256 (Jun. 1988).
Steuhr, D. J., et al, The Journal of Immunology, 139, No. 2, 518-525, (1987).
Schmidt, H. H. H. W., et al, European Journal of Pharmacology, 154, 213-216, (1988).
Steuhr, D. J., et al, J. Exp. Med. vol. 169, pp. 1011-1020 (Mar. 1989).
Stuehr, D. J., et al, J. Biochem. and Biophysical Research Communications, vol. 161, No. 2, pp. 420-426 (Jun. 15, 1989).
Turan, A., et al, Acta Chimica Academiae Scientiarum Hungaricae, Tomus 85 (3), pp. 327-332 (1975).
Kilbourn, R. G., et al, Proc. Natl. Acad. Sci. USA vol. 87, pp. 3629-3632, May 1990.
Sakuma, I., et al, Proc. Natl. Acad. Sci. USA vol. 85, pp. 8664-8667, Nov. 1988.
Gross, S. S., et al, Biochemical and Biophysical Research Communications, vol. 170, No. 1, pp. 96-103, Jul. 16, 1990.
Fasehun, O. A., et al, J. Pharmacol. Exp. Ther. 255, 1348-1358 (1990).
Greenstein, J. P., et al, Chemistry of Amino Acids, vol. 3, pp. 1850-1853, John Wiley & Sons, Inc., 1961.
Kilbourn, R., et al (1990), in "Nitric Oxide from L-Arginine: A Bioregulatory System" (S. Moncada and E. A. Higgs, eds, pp. 61-67, Elsevier Science Publishers, Amsterdam).
Natanson, C., et al, Journal of Exp. Med. 169:823-832 (1989).
Hibbs, J. B., et al, Biochem. Biophys. Res. Commun. 157:87-94 (1988).
Marletta, M. A., et al, Biochemistry 27:8706-8711 (1988).
Fukuto, M. J., et al, Biochem. Biophys. Res. Commun., 168: 458-465 (Apr. 1990).
Palmer, R. M. J., et al, Nature 327:524-526 (1987).
Kilbourn, R. G., et al, Biochem. and Biophys. Res. Commun., vol. 172, No. 3, 1132-1138 (Nov. 15, 1990).
Kilbourn, R. G., et al, Journal of the National Cancer Institute, vol. 82, No. 9, 772-776 (May 2, 1990).
Lambert, L. L., et al, Life Sciences, 48:69-75 (1991).
Billiar, T. R., et al, Journal of Leukocyte Biology 48:565-569 (1990).
Cornell Research Foundation Inc.
Hung Deborah L.
Robinson Douglas W.
LandOfFree
N.sup.6 -(hydrazinoiminomethyl)lysine and method of inhibiting n does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N.sup.6 -(hydrazinoiminomethyl)lysine and method of inhibiting n, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N.sup.6 -(hydrazinoiminomethyl)lysine and method of inhibiting n will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1542089